Boston Scientific to buy Schneider

Article

Catheter developer Boston Scientific of Natick, MA, announced this month the signing of an agreement to purchase Schneider Worldwide, a division of Pfizer's Medical Technology Group, for $2.1 billion in cash, pending regulatory approvals. Schneider

Catheter developer Boston Scientific of Natick, MA, announced this month the signing of an agreement to purchase Schneider Worldwide, a division of Pfizer's Medical Technology Group, for $2.1 billion in cash, pending regulatory approvals. Schneider Worldwide operates out of Bulach, Switzerland, and manufactures stents and angioplasty devices and accessories. Last year the division claimed sales of $330 million. The deal should close later this year.

By acquiring Schneider, Boston Scientific will gain access to high-growth areas of interventional medicine, and will be able to offer a broader range of products, including rapid exchange catheters and nylon balloon technology. The deal reflects Boston Scientific's strategy of expanding its share in the interventional medicine market: Last year the company acquired Target Therapeutics of Fremont, CA, another catheter developer with a solid position in interventional neuroradiology.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.